Close Menu
    SUBSCRIBE Login
    Monday, September 15
    0 Shopping Cart

    Browsing: HIV

    Medicine Shortage: Investors Focus On BIHL’s Plans for Sustainable Growth

    By

    The group said it has implemented pricing in some of the schemes that are underperforming and continues to ensure that each and every scheme becomes profitable and sustainable on its own.

    Botswana’s recent shortage of chronic medication in some parts of the country is more than a health story. It has real implications for Botswana Insurance Holdings Limited (BIHL), and by extension investors. 

    This post is only available to members. To access this post, you must subscribe.

    Investor Mail - logo slogan

    News

    Company

    Services

    Investor Mail © 2025. Developed by Verbosec.Spaces
    Investor Mail
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.